Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bell B. A., Kurczynski E. M., Bergman G. Inhibitors to monoclonal antibody purified factor VIII. Lancet. 1990 Sep 8;336(8715):638–638. doi: 10.1016/0140-6736(90)93444-t. [DOI] [PubMed] [Google Scholar]
- Burnouf T., Burnouf-Radosevich M., Huart J. J., Goudemand M. A highly purified factor VIII:c concentrate prepared from cryoprecipitate by ion-exchange chromatography. Vox Sang. 1991;60(1):8–15. doi: 10.1111/j.1423-0410.1991.tb00864.x. [DOI] [PubMed] [Google Scholar]
- Cash J. D. Coagulation factor VIII concentrates and the marketplace. Lancet. 1988 Jun 4;1(8597):1270–1270. doi: 10.1016/s0140-6736(88)92083-1. [DOI] [PubMed] [Google Scholar]
- Cash J. D. Supply of blood products. BMJ. 1991 Apr 6;302(6780):849–849. doi: 10.1136/bmj.302.6780.849-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kessler C. M., Sachse K. Factor VIII:C inhibitor associated with monoclonal-antibody purified FVIII concentrate. Lancet. 1990 Jun 9;335(8702):1403–1403. doi: 10.1016/0140-6736(90)91282-f. [DOI] [PubMed] [Google Scholar]
- Montoro J. B., Rodríguez S., Altisent C., Tusell J. M. Transient factor VIII inhibitor and treatment with monoclonal-antibody-purified factor VIII. Lancet. 1991 May 18;337(8751):1222–1222. doi: 10.1016/0140-6736(91)92891-5. [DOI] [PubMed] [Google Scholar]